Answers are grounded in this paper and cite their sources.
High-density lipoproteins (HDL) are well-known cardioprotective mediators. Dysfunctional HDL strongly contributes to increased cardiovascular mortality in chronic kidney disease (CKD) patients. Post-translational modifications (PTMs) of HDL proteins can lead to functional impairments of HDL. However, there is a lack of conclusive molecular data on the occurrence of PTMs in HDL from CKD patients compared to HDL isolated from healthy controls. Therefore, this study aimed to analyze PTMs major HDL protein apolipoprotein A-I (apo A-I) in these cohorts'.
No takes yet. Share an insight, caveat, or question.
Jankowski et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: